We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

772:HKEXChina Literature Ltd. Analysis

Data as of 2026-08-01 - not real-time

NT$58.20

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Microprogram Information Co.,Ltd is trading at TWD 58.2, essentially in line with its DCF‑derived fair value of 58.99, but well below its 20‑day SMA (64.6) and 50‑day SMA (71.5), indicating short‑term weakness. The 14‑day RSI sits at 34, suggesting the stock is approaching oversold territory, while the MACD remains bearish with the line below the signal. Volume has been on a decreasing trend, and the 30‑day volatility is high at 48 %, reflecting a choppy price environment. Valuation metrics are mixed: a trailing PE of 95.4 is far above the industry average of 32.8, yet the forward PE of 32.5 aligns more closely with peers. Revenue grew 20 % year‑over‑year and gross margins remain robust at 68 %, supporting a growth narrative. However, free cash flow is deeply negative and the debt‑to‑equity ratio of 17.5 signals substantial leverage.
The dividend yield of 1.72 % looks attractive, but a payout ratio exceeding 300 % makes the dividend unsustainable. Beta of 0.71 points to lower systematic risk, but the combination of high volatility, heavy debt and declining liquidity elevates overall risk. The company operates across Taiwan, Mainland China and Europe, exposing it to medium geographic and regulatory risk. Given these dynamics, the stock appears fairly valued, with growth‑oriented appeal for medium‑term investors but limited upside in the near term.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • price below short‑term moving averages
  • bearish MACD signal
  • high short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • 20% year‑over‑year revenue growth
  • forward PE of 32.5 aligns with industry
  • price matches DCF fair value

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • strong gross margins above 60%
  • elevated debt and negative free cash flow
  • dividend payout ratio unsustainable

Key Metrics & Analysis

Financial Health

Revenue Growth20.10%
Profit Margin6.17%
P/E Ratio95.4
ROE2.99%
ROA1.61%
Debt/Equity17.48
P/B Ratio2.6
Op. Cash FlowNT$147.1M
Free Cash FlowNT$-380554496
Industry P/E32.8

Technical Analysis

TrendNeutral
RSI34.0
SupportNT$55.10
ResistanceNT$76.00
MA 20NT$64.65
MA 50NT$71.51
MA 200NT$61.47
MACDBearish
VolumeDecreasing
Fear & Greed Index92.88

Valuation

Fair ValueNT$59.00
GradeFair
TypeGrowth
Dividend Yield1.72%

Risk Assessment

Beta0.71
Volatility48.34%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.